A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

NCT00366379 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: GK Activator (2)

Sponsor

Hoffmann-La Roche